Target intelligence / Profile preview

Long intergenic non-coding RNA (lincRNA)

Target
lincRNA
Molecular classification
Non-coding RNA, Long non-coding RNA (lncRNA), Intergenic non-coding RNA
01

Overview

Long intergenic non-coding RNAs (lincRNAs) are RNA transcripts greater than 200 nucleotides in length, transcribed from regions of the genome that do not overlap with protein-coding genes. They belong to the broader category of long non-coding RNAs and are distinguished by their genomic positioning, lack of protein-coding potential, and diverse regulatory functions, including roles in chromatin modification, transcriptional control, and genome architecture. lincRNAs have tissue-specific expression and are implicated in development, disease processes (such as cancer and neurodegeneration), and the fine-tuning of gene expression. Only a small fraction of thousands of lincRNAs have assigned biological functions, and their study is an active and rapidly evolving area of research.

Other names
long intergenic non-coding RNAlincRNA
02

Biological functions

Epigenetic regulation (e.g., chromatin remodeling, histone modification)Transcriptional regulation (gene activation/silencing)Scaffold for protein complexesRegulation of genome architecture and nuclear structureRNA stabilization and acting as decoys for other RNA/proteins
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular disease (in development and pathology)Other (autoimmunity, development, etc.)

Beyond the preview

Go deeper on Long intergenic non-coding RNA (lincRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-coding RNA (lincRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call